Genomics plc is a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools and to bring new understanding to drug discovery. Genomics was founded in 2014 by four world-leading statistical and human geneticists at the University of Oxford. Today, Genomics is collaborating with some of the world’s leading healthcare and drug-discovery organizations and helping them to predict, prevent, treat and cure – dramatically reducing the human and financial cost of common diseases like cancer and diabetes.
A Deadly Combination: The Dangers of Type 1 Diabetes and Disordered Eating
A deadly combination of type 1 diabetes and disordered eating, known as T1DE, poses significant risks to those affected. With complications ranging from severe health








